Zomedica looks like it will be a winner once its veterinarian office lab testing product launches on March 30. ZOM stock is already up 850% so far this year. In fact, it peaked at $2.70 in early February in anticipation of this product launch.Moreover, the company has very smart about taking advantage of its huge price spike. On Feb. 8, it raised another $185.4 million. In fact, as of Feb. 26, Zomedica had an astounding $277.5 million in cash on its balance sheet, based on an 8-K filing